{"id":821562,"date":"2025-03-04T13:21:36","date_gmt":"2025-03-04T18:21:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/"},"modified":"2025-03-04T13:21:36","modified_gmt":"2025-03-04T18:21:36","slug":"spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/","title":{"rendered":"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement"},"content":{"rendered":"<div class=\"mw_release\">\n<p>New York, NY, March  04, 2025  (GLOBE NEWSWIRE) &#8212;  Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $3,788,000 private placement for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sole placement agent in this private offering.<\/p>\n<p>The proceeds from this offering will further Lipella\u2019s mission to develop innovative therapies addressing significant unmet medical needs, while also funding general corporate purposes.<\/p>\n<p>Jonathan Kaufman, PhD, CEO of Lipella Pharmaceuticals, remains committed to leading the company\u2019s groundbreaking clinical pipeline and advancing transformative treatments.<\/p>\n<p>\u201cWe are honored to serve as the sole placement agent in this private placement for Lipella Pharmaceuticals,\u201d said John Lowry, CEO of Spartan Capital Securities. \u201cLipella\u2019s dedication to medical innovation and improving patient outcomes is commendable. This successful transaction underscores both the strength of Lipella\u2019s vision and Spartan Capital\u2019s commitment to facilitating impactful investment opportunities. We look forward to supporting Lipella\u2019s continued success.\u201d<\/p>\n<p>Sichenzia Ross Ference Carmel LLP served as placement agent counsel, while Sullivan &amp; Worcester LLP acted as counsel to Lipella Pharmaceuticals Inc.<\/p>\n<p>Further details on the transaction will be available in the Company\u2019s Form 8-K, to be filed with the U.S. Securities and Exchange Commission and accessible at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HEd2tDue3I41AHx8Y6PgizjNsku3DCz6o7SvdkrIKb3FywQA0h8pmhVM0_UTwcPUnHROqDBOAwio-Z0i8_HSCA==\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>.<\/p>\n<p>The common shares and the common shares issuable upon the conversion of related warrants have not been registered under the Securities Act of 1933, as amended, or any state securities laws. Until registered, these securities may not be offered or sold in the United States or any state absent registration or an applicable exemption from registration requirements.<\/p>\n<p>This press release does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction where such offer, solicitation, or sale would be unlawful prior to registration or qualification under applicable securities laws.<\/p>\n<p>About Spartan Capital Securities, LLC<\/p>\n<p>Spartan Capital Securities, LLC is a premier full-service investment banking firm offering a comprehensive range of advisory services to institutional clients and high-net-worth individuals. Known for its expertise in capital raising, strategic advisory, and asset management, Spartan Capital delivers tailored solutions to meet clients&#8217; financial goals.<\/p>\n<p>For more information about Spartan Capital Securities, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HEd2tDue3I41AHx8Y6Pgi13b7vIjLDcfmmBcFqM_KfBKY6M_dVjdhj81iwfnGofsh0U174wF6-2oTK7MwqBeZebewlg_8fWvhvj3AEohjnw=\" rel=\"nofollow\" target=\"_blank\">www.spartancapital.com<\/a>.<\/p>\n<p>Contact: Spartan Capital Securities, LLC 45 Broadway, 19th Floor New York, NY 10006 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tlHUmTzn_s4KcXo_4adYv9hqL0kOMuU3nOrPDNKjvA0GyIHun3wvrkeekvky-NaFOW_qZTbCLfWaUnY33StnXjmeuBI6UoRHmJf5puG_J0SgLifKx4KbimYBPif-rm92WU_uoTQXrfP37qqng-tmBA==\" rel=\"nofollow\" target=\"_blank\">investmentbanking@spartancapital.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjU5Y2I3ZmYtMjUwOS00MjFjLWIxYmEtZWJjOTQ3NWM1MjgxLTUwMDEyMzQzOA==\/tiny\/Spartan-Capital-Securities-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>New York, NY, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $3,788,000 private placement for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sole placement agent in this private offering. The proceeds from this offering will further Lipella\u2019s mission to develop innovative therapies addressing significant unmet medical needs, while also funding general corporate purposes. Jonathan Kaufman, PhD, CEO of Lipella Pharmaceuticals, remains committed to leading the company\u2019s groundbreaking clinical pipeline and advancing transformative treatments. \u201cWe are honored to serve as the sole placement agent in this private placement for Lipella Pharmaceuticals,\u201d said John Lowry, CEO of Spartan Capital Securities. \u201cLipella\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821562","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"New York, NY, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $3,788,000 private placement for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sole placement agent in this private offering. The proceeds from this offering will further Lipella\u2019s mission to develop innovative therapies addressing significant unmet medical needs, while also funding general corporate purposes. Jonathan Kaufman, PhD, CEO of Lipella Pharmaceuticals, remains committed to leading the company\u2019s groundbreaking clinical pipeline and advancing transformative treatments. \u201cWe are honored to serve as the sole placement agent in this private placement for Lipella Pharmaceuticals,\u201d said John Lowry, CEO of Spartan Capital Securities. \u201cLipella\u2019s &hellip; Continue reading &quot;Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T18:21:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement\",\"datePublished\":\"2025-03-04T18:21:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/\"},\"wordCount\":411,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/\",\"name\":\"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==\",\"datePublished\":\"2025-03-04T18:21:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/","og_locale":"en_US","og_type":"article","og_title":"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement - Market Newsdesk","og_description":"New York, NY, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $3,788,000 private placement for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sole placement agent in this private offering. The proceeds from this offering will further Lipella\u2019s mission to develop innovative therapies addressing significant unmet medical needs, while also funding general corporate purposes. Jonathan Kaufman, PhD, CEO of Lipella Pharmaceuticals, remains committed to leading the company\u2019s groundbreaking clinical pipeline and advancing transformative treatments. \u201cWe are honored to serve as the sole placement agent in this private placement for Lipella Pharmaceuticals,\u201d said John Lowry, CEO of Spartan Capital Securities. \u201cLipella\u2019s &hellip; Continue reading \"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-04T18:21:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement","datePublished":"2025-03-04T18:21:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/"},"wordCount":411,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/","name":"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==","datePublished":"2025-03-04T18:21:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODg2NCM2NzkwMzQ2IzUwMDEyMzQzOA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spartan-capital-securities-llc-serves-as-sole-placement-agent-in-lipella-pharmaceuticals-inc-s-3788000-private-placement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.\u2019s $3,788,000 Private Placement"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821562"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821562\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}